Dp. Heruth et al., INFLUENCE OF PROTEIN-TYROSINE PHOSPHORYLATION ON THE EXPRESSION OF THE C-MYC ONCOGENE IN CANCER OF THE LARGE-BOWEL, Journal of cellular biochemistry, 58(1), 1995, pp. 83-94
We tested the potential impact of tyrosine phosphorylation on the expr
ession of the c-myc gene in two colon cancer cell lines, HCT8 and SW83
7. We found that the protein tyrosine kinase inhibitor genistein cause
s a decrease in the abundance of c-myc RNA and an inhibition of prolif
eration with a similar dose response. Geldanamycin, a mechanistically
different tyrosine kinase inhibitor, also causes a decrease in both th
e expression of c-myc RNA and proliferation. Genistein has also been f
ound to inhibit topoisomerase II, but the topoisomerase II inhibitor n
ovobiocin did not lower the expression of c-myc. The most likely inter
pretation is that inhibition of protein tyrosine kinase activity cause
d a decrease in c-myc expression in these cells. The impact of tyrosin
e phosphorylation on the expression of the c-myc gene is further suppo
rted by the finding that inhibition of phosphotyrosine phosphatase usi
ng orthovanadate causes an increase in the level of c-myc RNA. The eff
ect of genistein on HCT8 cells is not dependent on the synthesis of ne
w protein and does not involve an alteration in the stability of the m
essage. Analysis of transcription in the c-myc gene reveals a more com
plicated picture with a decrease in initiation and an increase in elon
gation but no net change in transcription. We speculate that the genis
tein induced reduction in myc expression is the result of a posttransc
riptional intranuclear event(s). (C) 1995 Wiley-Liss, inc.